Falls and risk factors for falls in community-dwelling adults with dementia (NutriAlz Trial)
Por:
Salvà A., Roqué M., Rojano X., Inzitari M., Andrieu S., Schiffrin E.J., Guigoz Y., Vellas B.
Publicada:
1 ene 2012
Resumen:
To estimate the number of fallers and risk factors for falls in a cohort with dementia, we did a secondary analysis of a cluster-randomized controlled trial (NutriAlz) in 11 outpatient and day care centers in Catalonia (Spain) including 626 community-dwelling patients with dementia, followed for 12 months. Participants' characteristics were assessed at baseline, at 6 and 12 months [fall in the earlier 6 mo, anthropometric data, comorbidities, Mini-Mental State Examination, Clinical Dementia Rating, Basic Activities of Daily Living (BADL), Instrumental Activities of Daily Living, Neuropsychiatric Inventory Questionnaire, Zarit Caregiver Burden Interview and Mini-Nutritional Assessment]. Multivariate logistic regression models and generalized linear models were used to explore risk factors for falls and changes in health and function. Two hundred twenty-three participants fell during the 12 months follow-up (35.62%). Risk factors identified for falls were age (odds ratio (OR)=1.03, 95% confidence interval (CI), 1.00-1.05), BADL (OR=1.18, 95% CI, 1.05-1.32), and earlier fall (OR=2.30, 95% CI, 1.57-3.35). Fallers had worse health than nonfallers, and their dependence increased significantly more in BADL during the study, compared with nonfallers. Dependence in BADL is a risk factor and a consequence of falls; interventions aimed at preventing falls in dementia patients could promote autonomy in BADL and slow its decline. Copyright © 2012 by Lippincott Williams & Wilkins.
Filiaciones:
Salvà A.:
Institut de l'Envelliment, Universitat Autònoma de Barcelona, Sant Pau Institute of Biomedical Research (IIB-Sant Pau), Barcelona, Spain
Roqué M.:
Institut de l'Envelliment, Universitat Autònoma de Barcelona, Sant Pau Institute of Biomedical Research (IIB-Sant Pau), Barcelona, Spain
Rojano X.:
Institut de l'Envelliment, Universitat Autònoma de Barcelona, Sant Pau Institute of Biomedical Research (IIB-Sant Pau), Barcelona, Spain
Inzitari M.:
Institut de l'Envelliment, Universitat Autònoma de Barcelona, Sant Pau Institute of Biomedical Research (IIB-Sant Pau), Barcelona, Spain
Parc Sanitari Pere Virgili, Barcelona, Spain
Andrieu S.:
Inserm U558, University of Toulouse III, Toulouse, France
Schiffrin E.J.:
Nestlé Nutrition, Nestec Ltd, Vevey, Switzerland
Guigoz Y.:
Nestlé Nutrition, Nestec Ltd, Vevey, Switzerland
Vellas B.:
Inserm U558, University of Toulouse III, Toulouse, France
Gérontopôle, Hôpitaux de Toulouse, Toulouse, France
|